$PG

2 Dividend Kings, 1 Clear Winner: P&G vs. Colgate

Procter & Gamble (PG) and Colgate-Palmolive (CL) recently paid dividends. PG offers a higher yield (2.93%) and better coverage, while CL has stronger recent price performance. PG plans to return $15B to shareholders in fiscal 2027, including $10B in dividends. CL trades at a higher P/E (35x) with a smaller yield (2.33%).

Original reporting
Published Sep 2, 2026, 5:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 11:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
2 Dividend Kings, 1 Clear Winner: P&G vs. Colgate — source image
Decision brief

The 30-second read

$PGBullishMed
01

Why it matters

The new guidance from P&G could reinforce its dividend‑king status, while Colgate's modest returns may limit its appeal despite recent price gains.

02

Market read

Fresh dividend and buyback guidance for two major consumer staples firms provides actionable insight for income‑focused investors.

03

What to watch

Potential pressure on P&G's margin from higher payout and macro‑inflation risks.

Relevance 8/10Novelty 7/10Timing: guidance disclosed today

Background

Both companies are long‑standing Dividend Kings, and the article compares their recent dividend payouts and guidance.

Company-level read

Ticker impact

$PGBullishHigh confidence
Context

P&G announced FY2027 dividend of over $10 billion and $5 billion share repurchase guidance.

Expected impact

Potential modest upside if market prices in the higher payout.

Evidence & confidence

Guidance is a fresh, material disclosure from a large cap with significant cash return plan.

$CLNeutralMedium confidence
Context

Colgate disclosed FY2026 dividend of $0.53 per share and $1.4 billion shareholder return for H1 2026.

Expected impact

Limited upside; price may stay range‑bound unless earnings beat expectations.

Evidence & confidence

The information is new but less material than P&G’s guidance.

Market effects

Highlights strength of consumer‑staples dividend sector, may attract yield‑seeking capital.

U.S. large‑cap dividend stocks could see modest inflows.

Sets a benchmark for global dividend‑king peers.

Counterpoint

Colgate's higher price performance despite lower payout suggests market may favor growth over yield.

Key entities

  • Procter & Gamble

    Consumer‑goods giant, Dividend King, FY2027 dividend guidance.

  • Colgate‑Palmolive

    Oral‑care and consumer products company, Dividend King, FY2026 dividend update.

Related articles

$CLMed

Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.

$CLMedAI 8/10

Colgate-Palmolive Explores Sale Of Softsoap, Irish Spring, Speed Stick Brands: Report

Colgate-Palmolive (CL) is exploring the sale of brands like Softsoap, Irish Spring, and Speed Stick, potentially fetching over $1 billion. The company is working with Goldman Sachs (GS) on the divestiture. Personal care accounted for 17% of CL's 2025 net sales, which totaled $20.38 billion. The move is part of a broader productivity and restructuring program aimed at generating annual pre-tax savings of $200 million to $300 million by 2028.

$CLMedAI 8/10

Colgate-Palmolive reportedly weighs US$1B personal care offload.

Colgate-Palmolive is reportedly considering the sale of select mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, for over $1 billion. The company is working with Goldman Sachs on the potential divestment to focus on higher-margin businesses amid North American competition. Personal care accounted for 17% of its 2025 net sales of $20.38 billion.

$CLMed

CL Stock Alert: Colgate-Palmolive Reportedly Considers $1 Billion Brand Sale

Colgate-Palmolive (CL) is reportedly exploring the sale of non-core personal care brands, valued at over $1 billion, with Goldman Sachs' advisory. The move aims to reallocate capital toward higher-growth segments. CL shares are down 12% year-to-date, trading below major moving averages, but offer a 2.44% dividend yield. Institutional investors remain bullish, and the consensus rating is 'Moderate Buy' with a mean price target of $160.

$CLMedAI 8/10

Colgate-Palmolive Seeks Value Through Portfolio Reshaping

Colgate-Palmolive (NYSE:CL) is exploring the sale of mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, potentially generating over $1 billion. The move aims to simplify its portfolio and focus on higher-growth areas like oral care and pet nutrition, amid competitive pressure in North America. The company reported a 4.9% increase in net sales, but organic sales in North America declined 3%. Proceeds could be used for debt reduction, share repurchases, or acquisi